Latest Breaking News On - Michaelr minogue - Page 1 : comparemela.com

Johnson & Johnson to acquire Abiomed

The upfront payment for all shares of the company, which specializes in technologies for heart recovery, is valued at $16.6B.

Johnson & Johnson to Acquire Abiomed

Johnson & Johnson (NYSE: JNJ), the world’s largest, most diversified healthcare products company, and Abiomed (NASDAQ: ABMD), a world leader in breakthrough heart, lung and kidney support technologies, today announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire .

Abiomed stock soars on Q3 results, Johnson & Johnson to acquire

Abiomed shares soared today on third-quarter results and the news of its acquisition by Johnson & Johnson.

Johnson & Johnson (JNJ) Acquires Abiomed (ABMD) for $380/sh or $16.6B, Plus CVR Worth Up to $35/sh

Johnson & Johnson to Acquire Abiomed

Transaction to bring lifesaving innovations to more patients with unmet need